PTX 0.00% 4.0¢ prescient therapeutics limited

Ann: Rodman & Renshaw Global Investment Conference Presentation, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,075 Posts.
    lightbulb Created with Sketch. 43
    Agree bsher..., great presentation.
    A misleading assumption with Biotech investments is the fallacy of not much happening between trial dates, hence impatience sets in.
    Sometimes on the contrary, for example the now de-listed VLA. That is, upon good results the SP climbed to approximately $1.20 (of memory) yet over a period of 6 months or so demised to an SP of around 65cents.
    Yet, behind the scenes, negotiations were taking place and the rest is now history as they say.
    Not suggesting a similarity here nor any knowledge of behind the scenes either.
    Point being, until publicly announced, we keep accumulating.
    Luck to holders.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.